参考文献/References:
[1] 姚树桥,杨艳春,杨艳杰,等. 医学心理学[Z]. 北京:人民卫生出版社,2013.
[2] United Nations, Department of Economic and Social Affairs, Population Division(2017). World Population Prospects: The 2017 Revision, Key Findings and Advance Tables[R]. Working Paper No. ESA/P/WP/248,2017.
[3] Prince PM, Wimo PA, Guerchet DM, et al. World Alzheimer Report 2015[R].London: Alzheimer’s Disease International,2015.
[4] Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care[J].Lancet,2017,390(10113):2673-2734.
[5] Lu J,Lu Y,Wang X,et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study(China PEACE Million Persons Project)[J]. Lancet,2017,390(10112):2549-2558.
[6] 郭艺芳. 规范应用降压药,积极防控高血压[J]. 心血管病学进展,2015,36(6):661-662.
[7] Rovio SP,Pahkala K,Nevalainen J,et al. Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study[J]. J Am Coll Cardiol,2017,69(18):2279-2289.
[8] Gottesman RF,Schneider ALC,Albert M,et al. Midlife hypertension and 20-year cognitive change:the atherosclerosis risk in communities neurocognitive study[J]. JAMA Neurol,2014,71(10):1218.
[9] Kohler S,Baars MA,Spauwen P,et al. Temporal evolution of cognitive changes in incident hypertension: prospective cohort study across the adult age span[J]. Hypertension,2014,63(2):245-251.
[10] Nishtala A,Himali JJ,Beiser A,et al. Midlife hypertension risk and cognition in?the non-demented oldest old: Framingham Heart Study[J]. J Alzheimers Dis,2015,47(1):197-204.
[11] Waldstein SR, Giggey PP, Thayer JF, et al. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging[J]. Hypertension,2005,45(3):374-379.
[12] Euser SM,van Bemmel T,Schram MT,et al. The effect of age on the association between blood pressure and cognitive function later in life[J]. J Am Geriatr Soc,2009,57(7):1232-1237.
[13] González HM,Tarraf W,Harrison K,et al. Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results[J]. Alzheimers Dement,2018,14(5):579-589.
[14] Launer LJ,Masaki K,Petrovitch H,et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study[J]. JAMA,1995,274(23):1846-1851.
[15] Obisesan TO, Obisesan OA, Martins S, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: The Third National Health and Nutrition Examination Survey[J]. J Am Geriatr Soc,2008,56(3):501-509.
[16] Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline[J]. Neurology,2011,77(5):461-468.
[17] Dregan A,Stewart R,Gulliford MC. Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study[J]. Age Ageing,2013,42(3):338-345.
[18] Kujawski S,Kujawska A,Gajos M,et al. Cognitive Functioning In Older People. Results Of The First Wave Of Cognition Of Older People, Education, Recreational Activities, Nutrition, Comorbidities, Functional Capacity Studies (COPERNICUS)[J]. Fronti Aging Neurosci,2018,10:421.
[19] Sabayan B,Oleksik AM,Maier AB,et al. High blood pressure and resilience to physical and cognitive decline in the oldest old:the Leiden 85-plus Study[J]. J Am Geriatr Soc,2012,60(11):2014-2019.
[20] Harrison SL, Stephan BC, Siervo M, et al. Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study[J]. J Am Geriatr Soc,2015,63(4):667-675.
[21] Hebert LE, Scherr PA, Bennett DA, et al. Blood pressure and late-life cognitive function change: a biracial longitudinal population study[J]. Neurology,2004,62(11):2021-2024.
[22] Johnson KC, Margolis KL, Espeland MA, et al. A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women’s Health Initiative Memory Study[J]. J Am Geriatr Soc,2008,56(8):1449-1458.
[23] Knopman D,Boland LL,Mosley T,et al. Cardiovascular risk factors and cognitive decline in middle-aged adults[J]. Neurology,2001,56(1):42-48.
[24] Mitchell GF. Cerebral small vessel disease: role of aortic stiffness and pulsatile hemodynamics[J]. J Hypertens,2015,33(10):2025-2028.
[25] Faraco G,Sugiyama Y,Lane D,et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension[J]. J Clin Invest,2016,126(12):4674-4689.
[26] Gupta A,Iadecola C. Impaired Aβ clearance:a potential link between atherosclerosis and Alzheimer’s disease[J]. Front Aging Neurosci,2015,7:115.
[27] Faraco G,Iadecola C. Hypertension:a harbinger of stroke and dementia[J]. Hypertension,2013,62(5):810-817.
[28] Kao Y,Chou M,Chen C,et al. White matter changes in patients with alzheimer’s disease and associated factors[J]. J Clin Med,2019,8(2):167.
[29] Katusic Z S, Austin S A. Endothelial nitric oxide: protector of a healthy mind[J]. European Heart Journal,2014,35(14):888-894.
[30] Nippert AR, Biesecker KR, Newman EA. Mechanisms mediating functional hyperemia in the brain[J]. Neuroscientist,2018,24(1):73-83.
[31] Calcinaghi N,Wyss MT,Jolivet R,et al. Multimodal imaging in rats reveals impaired neurovascular coupling in sustained hypertension[J]. Stroke,2013,44(7):1957-1964.
[32] Rosenberg GA,Wallin A,Wardlaw JM,et al. Consensus statement for diagnosis of subcortical small vessel disease[J]. J Cereb Blood Flow Metab,2015,36(1):6-25.
[33] Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs standard blood pressure control on probable dementia[J]. JAMA,2019,321(6):553.
[34] Bosch J,O’Donnell M,Swaminathan B,et al. Effects of blood pressure and lipid lowering on cognition[J]. Neurology,2019,10:1212.
[35] Levi Marpillat N,Macquin-Mavier I,Tropeano A,et al. Antihypertensive classes, cognitive decline and incidence of dementia:a network meta-analysis[J]. J Hypertens,2013,31(6):1073-1082.
[36] Zou K,Yamaguchi H,Akatsu H,et al. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition[J]. J Neurosci,2007,27(32):8628-8635.
[37] Rouch L,Cestac P,Hanon O,et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms[J]. CNS Drugs,2015,29(2):113-130.
[38] Gelber RP, Ross GW, Petrovitch H, et al. Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study[J]. Neurology,2013,81(10):888-895.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(7):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(7):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(7):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[8]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(7):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[9]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(7):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[10]付士辉李玉龙骆雷鸣沈明志田进文邓珏琳.高血压基础研究现状与进展[J].心血管病学进展,2019,(9):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]
FU ShihuiLI YulongLUO LeimingSHEN MingzhiTIAN JinwenDENG Juelin.Status and Progress of Basic Researches about Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):1202.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.004]
[11]姚苗苗,秦虹云,胡承平.高血压病对认知功能影响的研究进展[J].心血管病学进展,2020,(3):284.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.017]
YAO Miaomiao,QIN Hongyun,HU Chengping.Effect of Hypertension on Cognition[J].Advances in Cardiovascular Diseases,2020,(7):284.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.017]